These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3048124)

  • 1. PTSD and carbamazepine.
    Lipper S
    Am J Psychiatry; 1988 Oct; 145(10):1322-3. PubMed ID: 3048124
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary study of carbamazepine in post-traumatic stress disorder.
    Lipper S; Davidson JR; Grady TA; Edinger JD; Hammett EB; Mahorney SL; Cavenar JO
    Psychosomatics; 1986 Dec; 27(12):849-54. PubMed ID: 3543990
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacology and posttraumatic stress disorder.
    Platman SR
    Int J Emerg Ment Health; 1999; 1(3):195-9. PubMed ID: 11232390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin response to low-dose dexamethasone challenge in combat-exposed veterans with and without posttraumatic stress disorder and normal controls.
    Grossman R; Yehuda R; Boisoneau D; Schmeidler J; Giller EL
    Biol Psychiatry; 1996 Dec; 40(11):1100-5. PubMed ID: 8931912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclics: possible treatment for posttraumatic stress disorder.
    Falcon S; Ryan C; Chamberlain K; Curtis G
    J Clin Psychiatry; 1985 Sep; 46(9):385-8. PubMed ID: 3897205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 7. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
    Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A
    J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol treatment of post-traumatic stress disorder.
    Kaplan Z; Amir M; Swartz M; Levine J
    Anxiety; 1996; 2(1):51-2. PubMed ID: 9160600
    [No Abstract]   [Full Text] [Related]  

  • 9. Posttraumatic stress disorder in Vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine.
    Wolf ME; Alavi A; Mosnaim AD
    Biol Psychiatry; 1988 Mar; 23(6):642-4. PubMed ID: 3355879
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone therapy for post-traumatic stress disorder.
    Siddiqui Z; Marcil WA; Bhatia SC; Ramaswamy S; Petty F
    J Psychiatry Neurosci; 2005 Nov; 30(6):430-1. PubMed ID: 16327877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy treatment of PTSD and comorbid disorders.
    Kozarić-Kovacić D
    Psychiatr Danub; 2009 Sep; 21(3):411-4. PubMed ID: 19794366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative delay Pavlovian eyeblink conditioning in veterans with and without posttraumatic stress disorder.
    Ginsberg JP; Ayers E; Burriss L; Powell DA
    J Anxiety Disord; 2008 Jun; 22(5):809-23. PubMed ID: 17913453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychopharmotherapy of battle post-traumatic stress disorders (review of clinical research reports)].
    Reshetnikov VA; Reznik AM
    Voen Med Zh; 2009 Mar; 330(3):42-7. PubMed ID: 19530458
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome and depression in war veterans with post-traumatic stress disorder.
    Jakovljević M; Babić D; Crncević Z; Martinac M; Maslov B; Topić R
    Psychiatr Danub; 2008 Sep; 20(3):406-10. PubMed ID: 18827772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course and treatment of combat post-traumatic disorders].
    Malashenko OI; Novikov VA; Laskov VB; Pogosov AV
    Voen Med Zh; 2009 Mar; 330(3):48-53. PubMed ID: 19530459
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder.
    Bachmann AW; Sedgley TL; Jackson RV; Gibson JN; Young RM; Torpy DJ
    Psychoneuroendocrinology; 2005 Apr; 30(3):297-306. PubMed ID: 15511603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of mirtazapine as treatment for combat-related PTSD.
    Alderman CP; Condon JT; Gilbert AL
    Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of PTSD symptoms with use of duloxetine.
    Deneys ML; Ahearn EP
    J Clin Psychiatry; 2006 Mar; 67(3):496-7. PubMed ID: 16649841
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbamazepine for PTSD.
    Looff D; Grimley P; Kuller F; Martin A; Shonfield L
    J Am Acad Child Adolesc Psychiatry; 1995 Jun; 34(6):703-4. PubMed ID: 7608041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.